The cytotoxic role of RREB1, ZIP3 zinc transporter, and zinc in human pancreatic adenocarcinoma

References

• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62:10 - 29; http://dx.doi.org/10.3322/caac.20138; PMID: 22237781
   PubMed Web of Science ®Google Scholar
• Franklin RB, Costello LC. The important role of the apoptotic effects of zinc in the development of cancers. J Cell Biochem 2009; 106:750 - 7; http://dx.doi.org/10.1002/jcb.22049; PMID: 19160419
   PubMed Web of Science ®Google Scholar
• Franklin RB, Costello LC. Zinc as an anti-tumor agent in prostate cancer and in other cancers. Arch Biochem Biophys 2007; 463:211 - 7; http://dx.doi.org/10.1016/j.abb.2007.02.033; PMID: 17400177
   PubMed Web of Science ®Google Scholar
• Costello LC, Franklin RB. Cytotoxic/tumor suppressor role of zinc for the treatment of cancer: an enigma and an opportunity. Expert Rev Anticancer Ther 2012; 12:121 - 8; http://dx.doi.org/10.1586/era.11.190; PMID: 22149438
   PubMed Web of Science ®Google Scholar
• Costello LC, Franklin RB. A review of the current status and concept of the emerging implications of zinc and zinc transporters in the development of pancreatic cancer. Pancreat Disord Ther 2013; Suppl 4 PMID: 24195024
   PubMedGoogle Scholar
• Costello LC, Levy BA, Desouki MM, Zou J, Bagasra O, Johnson LA, Hanna N, Franklin RB. Decreased zinc and downregulation of ZIP3 zinc uptake transporter in the development of pancreatic adenocarcinoma. Cancer Biol Ther 2011; 12:297 - 303; http://dx.doi.org/10.4161/cbt.12.4.16356; PMID: 21613827
   PubMed Web of Science ®Google Scholar
• Costello LC, Zou J, Desouki MM, Franklin RB. Evidence for changes in RREB-1, ZIP3, and Zinc in the early development of pancreatic adenocarcinoma. J Gastrointest Cancer 2012; 43:570 - 8; http://dx.doi.org/10.1007/s12029-012-9378-1; PMID: 22427155
   PubMedGoogle Scholar
• Mao X, Schimmer AD. The toxicology of Clioquinol. Toxicol Lett 2008; 182:1 - 6; http://dx.doi.org/10.1016/j.toxlet.2008.08.015; PMID: 18812216
   PubMed Web of Science ®Google Scholar
• Bareggi SR, Cornelli U. Clioquinol: review of its mechanisms of action and clinical uses in neurodegenerative disorders. CNS Neurosci Ther 2012; 18:41 - 6; http://dx.doi.org/10.1111/j.1755-5949.2010.00231.x; PMID: 21199452
   PubMed Web of Science ®Google Scholar
• Donadelli M, Dalla Pozza E, Scupoli MT, Costanzo C, Scarpa A, Palmieri M. Intracellular zinc increase inhibits p53(-/-) pancreatic adenocarcinoma cell growth by ROS/AIF-mediated apoptosis. Biochim Biophys Acta 2009; 1793:273 - 80; http://dx.doi.org/10.1016/j.bbamcr.2008.09.010; PMID: 18951928
   PubMed Web of Science ®Google Scholar
• Jayaraman AK, Jayaraman S. Increased level of exogenous zinc induces cytotoxicity and up-regulates the expression of the ZnT-1 zinc transporter gene in pancreatic cancer cells. J Nutr Biochem 2011; 22:79 - 88; http://dx.doi.org/10.1016/j.jnutbio.2009.12.001; PMID: 20392624
   PubMed Web of Science ®Google Scholar
• Donadelli M, Dalla Pozza E, Costanzo C, Scupoli MT, Scarpa A, Palmieri M. Zinc depletion efficiently inhibits pancreatic cancer cell growth by increasing the ratio of antiproliferative/proliferative genes. J Cell Biochem 2008; 104:202 - 12; http://dx.doi.org/10.1002/jcb.21613; PMID: 17979179
   PubMed Web of Science ®Google Scholar
• Li M, Zhang Y, Liu Z, Bharadwaj U, Wang H, Wang X, Zhang S, Liuzzi JP, Chang SM, Cousins RJ, et al. Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression. Proc Natl Acad Sci U S A 2007; 104:18636 - 41; http://dx.doi.org/10.1073/pnas.0709307104; PMID: 18003899
   PubMed Web of Science ®Google Scholar
• Li M, Zhang Y, Bharadwaj U, Zhai QJ, Ahern CH, Fisher WE, Brunicardi FC, Logsdon CD, Chen C, Yao Q. Down-regulation of ZIP4 by RNA interference inhibits pancreatic cancer growth and increases the survival of nude mice with pancreatic cancer xenografts. Clin Cancer Res 2009; 15:5993 - 6001; http://dx.doi.org/10.1158/1078-0432.CCR-09-0557; PMID: 19755388
   PubMed Web of Science ®Google Scholar
• Yang J, Zhang Y, Cui X, Yao W, Yu X, Cen P, Hodges SE, Fisher WE, Brunicardi FC, Chen C, et al. Gene profile identifies zinc transporters differentially expressed in normal human organs and human pancreatic cancer. Curr Mol Med 2013; 13:401 - 9; PMID: 23331012
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yang J, Cui X, Chen Y, Zhu VF, Hagan JP, Wang H, Yu X, Hodges SE, Fang J, et al. A novel epigenetic CREB-miR-373 axis mediates ZIP4-induced pancreatic cancer growth. EMBO Mol Med 2013; 5:1322 - 34; http://dx.doi.org/10.1002/emmm.201302507; PMID: 23857777
   PubMed Web of Science ®Google Scholar
• Cui X, Zhang Y, Yang J, Sun X, Hagan JP, Guha S, Li M. ZIP4 confers resistance to zinc deficiency-induced apoptosis in pancreatic cancer. Cell Cycle 2014; 13:1180 - 6; http://dx.doi.org/10.4161/cc.28111; PMID: 24553114
   PubMed Web of Science ®Google Scholar
• Costello LC, Fenselau CC, Franklin RB. Evidence for operation of the direct zinc ligand exchange mechanism for trafficking, transport, and reactivity of zinc in mammalian cells. J Inorg Biochem 2011; 105:589 - 99; http://dx.doi.org/10.1016/j.jinorgbio.2011.02.002; PMID: 21440525
   PubMed Web of Science ®Google Scholar
• Jansen RJ, Robinson DP, Frank RD, Anderson KE, Bamlet WR, Oberg AL, Rabe KG, Olson JE, Sinha R, Petersen GM, et al. Fatty acids found in dairy, protein and unsaturated fatty acids are associated with risk of pancreatic cancer in a case-control study. Int J Cancer 2014; 134:1935 - 46; http://dx.doi.org/10.1002/ijc.28525; PMID: 24590454
   PubMed Web of Science ®Google Scholar
• Farzin L, Moassesi ME, Sajadi F, Faghih MAA. Evaluation of trace elements in pancreatic cancer patients in Iran. Middle East J Cancer 2013; 4:79 - 86
   Google Scholar
• Fabris C, Farini R, Del Favero G, Gurrieri G, Piccoli A, Sturniolo GC, Panucci A, Naccarato R. Copper, zinc and copper/zinc ratio in chronic pancreatitis and pancreatic cancer. Clin Biochem 1985; 18:373 - 5; http://dx.doi.org/10.1016/S0009-9120(85)80078-3; PMID: 4092355
   PubMed Web of Science ®Google Scholar
• Thiagalingam A, De Bustros A, Borges M, Jasti R, Compton D, Diamond L, Mabry M, Ball DW, Baylin SB, Nelkin BD. RREB-1, a novel zinc finger protein, is involved in the differentiation response to Ras in human medullary thyroid carcinomas. Mol Cell Biol 1996; 16:5335 - 45; PMID: 8816445
   PubMed Web of Science ®Google Scholar
• Liu H, Hew HC, Lu ZG, Yamaguchi T, Miki Y, Yoshida K. DNA damage signalling recruits RREB-1 to the p53 tumour suppressor promoter. Biochem J 2009; 422:543 - 51; http://dx.doi.org/10.1042/BJ20090342; PMID: 19558368
   PubMed Web of Science ®Google Scholar
• Jiang W, Sequeira JM, Nakayama Y, Lai SC, Quadros EV. Characterization of the promoter region of TCblR/CD320 gene, the receptor for cellular uptake of transcobalamin-bound cobalamin. Gene 2010; 466:49 - 55; http://dx.doi.org/10.1016/j.gene.2010.07.004; PMID: 20627121
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay NK, Cinar B, Mukhopadhyay L, Lutchman M, Ferdinand AS, Kim J, Chung LW, Adam RM, Ray SK, Leiter AB, et al. The zinc finger protein ras-responsive element binding protein-1 is a coregulator of the androgen receptor: implications for the role of the Ras pathway in enhancing androgenic signaling in prostate cancer. Mol Endocrinol 2007; 21:2056 - 70; http://dx.doi.org/10.1210/me.2006-0503; PMID: 17550981
   PubMed Web of Science ®Google Scholar
• Flajollet S, Poras I, Carosella ED, Moreau P. RREB-1 is a transcriptional repressor of HLA-G. J Immunol 2009; 183:6948 - 59; http://dx.doi.org/10.4049/jimmunol.0902053; PMID: 19890057
   PubMed Web of Science ®Google Scholar
• Kent OA, Fox-Talbot K, Halushka MK. RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets. Oncogene 2013; 32:2576 - 85; http://dx.doi.org/10.1038/onc.2012.266; PMID: 22751122
   PubMed Web of Science ®Google Scholar
• Milon BC, Agyapong A, Bautista R, Costello LC, Franklin RB. Ras responsive element binding protein-1 (RREB-1) down-regulates hZIP1 expression in prostate cancer cells. Prostate 2010; 70:288 - 96; PMID: 19802870
   PubMed Web of Science ®Google Scholar
• Oxford G, Smith SC, Hampton G, Theodorescu D. Expression profiling of Ral-depleted bladder cancer cells identifies RREB-1 as a novel transcriptional Ral effector. Oncogene 2007; 26:7143 - 52; http://dx.doi.org/10.1038/sj.onc.1210521; PMID: 17496927
   PubMed Web of Science ®Google Scholar
• Scarlett CJ, Salisbury EL, Biankin AV, Kench J. Precursor lesions in pancreatic cancer: morphological and molecular pathology. Pathology 2011; 43:183 - 200; http://dx.doi.org/10.1097/PAT.0b013e3283445e3a; PMID: 21436628
   PubMed Web of Science ®Google Scholar
• Morris JP 4th, Wang SC, Hebrok M. KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. Nat Rev Cancer 2010; 10:683 - 95; http://dx.doi.org/10.1038/nrc2899; PMID: 20814421
   PubMed Web of Science ®Google Scholar
• Murtaugh LC. Pathogenesis of pancreatic cancer: lessons from animal models. Toxicol Pathol 2014; 42:217 - 28; http://dx.doi.org/10.1177/0192623313508250; PMID: 24178582
   PubMedGoogle Scholar
• De La O JP, Emerson LL, Goodman JL, Froebe SC, Illum BE, Curtis AB, Murtaugh LC. Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia. Proc Natl Acad Sci U S A 2008; 105:18907 - 12; http://dx.doi.org/10.1073/pnas.0810111105; PMID: 19028876
   PubMed Web of Science ®Google Scholar
• Rooman I, Real FX. Pancreatic ductal adenocarcinoma and acinar cells: a matter of differentiation and development?. Gut 2012; 61:449 - 58; http://dx.doi.org/10.1136/gut.2010.235804; PMID: 21730103
   PubMed Web of Science ®Google Scholar
• Shi C, Hong SM, Lim P, Kamiyama H, Khan M, Anders RA, Goggins M, Hruban RH, Eshleman JR. KRAS2 mutations in human pancreatic acinar-ductal metaplastic lesions are limited to those with PanIN: implications for the human pancreatic cancer cell of origin. Mol Cancer Res 2009; 7:230 - 6; http://dx.doi.org/10.1158/1541-7786.MCR-08-0206; PMID: 19208745
   PubMed Web of Science ®Google Scholar
• Zhu L, Shi G, Schmidt CM, Hruban RH, Konieczny SF. Acinar cells contribute to the molecular heterogeneity of pancreatic intraepithelial neoplasia. Am J Pathol 2007; 171:263 - 73; http://dx.doi.org/10.2353/ajpath.2007.061176; PMID: 17591971
   PubMed Web of Science ®Google Scholar
• Ray SK, Nishitani J, Petry MW, Fessing MY, Leiter AB. Novel transcriptional potentiation of BETA2/NeuroD on the secretin gene promoter by the DNA-binding protein Finb/RREB-1. Mol Cell Biol 2003; 23:259 - 71; http://dx.doi.org/10.1128/MCB.23.1.259-271.2003; PMID: 12482979
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248 - 54; http://dx.doi.org/10.1016/0003-2697(76)90527-3; PMID: 942051
   PubMed Web of Science ®Google Scholar
• Desouki MM, Geradts J, Milon B, Franklin RB, Costello LC. hZip2 and hZip3 zinc transporters are down regulated in human prostate adenocarcinomatous glands. Mol Cancer 2007; 6:37; http://dx.doi.org/10.1186/1476-4598-6-37; PMID: 17550612
   PubMed Web of Science ®Google Scholar